US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by F-star Therapeutics, Inc.

News headline image
F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies
From F-star Therapeutics, Inc.
Via GlobeNewswire
News headline image
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
News headline image
invoX Pharma and F-star Therapeutics issue Joint Statement
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
News headline image
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
News headline image
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX